DuPont Nutrition Avicel PH101 PH102 PH200 NF: Out of Specification Conductivity Risk
DuPont Nutrition recalls bulk cellulose powder PH101 NF, PH102 NF, PH200 NF due to conductivity testing failures. These excipients may not meet quality standards for pharmaceutical use.
Lower-risk recall
Out of specification results for conductivity.
Contact the company
What happened, in plain English
DuPont Nutrition is recalling specific bulk cellulose powders (PH101 NF, PH102 NF, PH200 NF) because they failed conductivity tests. This affects pharmaceutical manufacturing where precise material properties are critical. Read more at govinfonow.com/recall/35990-dupont-nutrition-avicel-ph101-ph102-ph200-nf-out-of-specification.
Source Summary by GovInfoNow · govinfonow.com/recall/35990-dupont-nutrition-avicel-ph101-ph102-ph200-nf-out-of-specification · Updated August 18, 2026 · FDA enforcement record: FDA #D-0728-2021
Cite this page
“DuPont Nutrition Avicel PH101 PH102 PH200 NF: Out of Specification Conductivity Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35990-dupont-nutrition-avicel-ph101-ph102-ph200-nf-out-of-specification. Based on FDA recall #D-0728-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0728-2021%22&limit=1).
Why it’s dangerous
The recalled cellulose powders failed conductivity testing, meaning they don't meet the required specifications for pharmaceutical use. This could lead to inconsistent drug performance or safety issues in manufacturing processes.
Who’s affected
Pharmaceutical manufacturers using these specific cellulose powders in drug production are affected. Those handling the recalled lots without proper quality checks may be at risk.
How to tell if you have this one
Check if you have bulk cellulose powder labeled PH101 NF, PH102 NF, or PH200 NF from DuPont Nutrition USA, Inc. Lot numbers include the listed sequences like P120834253 or 2173728724.
- Brand
DuPont Nutrition- Category
Drug
What to do — step by step
Check Product Lot Numbers
Verify if your product matches the listed lot numbers: P120834253, PN20834314, PN20834326, P220834329, etc.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “Product was distributed nationwide, including Puerto Rico and to foreign accounts abroad.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 19 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Do I need to stop using these products?
No, these are industrial materials for pharmaceutical manufacturing, not consumer products. The recall is for manufacturers, not end-users.
What should I do if I have these products?
Contact DuPont Nutrition USA, Inc. to confirm if your lot numbers are affected and follow their instructions for handling.
Are there any expiration dates for these products?
The recall notes these excipients do not have an expiration date.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0728-2021 (August 5, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0728-2021 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.